Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal
Yosemite has closed its cancer-focused second fund at $350 million, a serious jump from January’s first close at $200 million, investor Reed Jobs exclusively told Fortune.
We haven't written up this one. Fortune has the full story — the link below goes straight to it.